| Authors: |
Llibre JM; Infectious Diseases, Division and Fight Infections Foundation, University Hospital Germans Trias, Badalona, Barcelona, Spain.; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain., Ripamonti D; Infectious Diseases Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Geretti AM; Department of Systems Medicine, Infectious Diseases Unit, University of Rome Tor Vergata, Rome, Italy.; Department of HIV Medicine, Royal Free London NHS Trust, London, United Kingdom., Martin-Iguacel R; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.; Centre of Epidemiological Studies of HIV/AIDS and STI of Catalonia (CEEISCAT), Badalona, Spain., Sax PE; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Gupta RK; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Africa Health Research Institute, KwaZulu-Natal, South Africa., Shafer RW; Stanford University Medical School, Stanford, Infectious diseases, California, USA., Schapiro JM; National Hemophilia Center, Sheba Medical Center, Tel Aviv, Israel., Kuritzkes DR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Mesplède T; Viroscience Department, Erasmus University Medical Center, Rotterdam, The Netherlands. |